June 2022 Journal Watch
Published 1 May 2022
The June 2022 Journal Watch explores PEDS topics including:
- Survival difference between high-risk and low-risk (CFTR) genotypes after lung transplant
- Ex vivo enzymatic treatment converts blood type A donor lungs into universal blood type lungs
- Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis
Issue Editor:
Kyle Hope, MD, MS
Additional Contributors:
ELLIOTT DAVIS, MBBS, BSc (Hons)
Great Ormond Street Hospital, London, UK
NICOLA RONAN, MBBCh, PhD
Royal Papworth Hospital, Cambridge, UK
ILARIA TESTA, MD
Great Ormond Street Hospital, London, UK